PNNL will lead three new grid modernization projects funded by the Department of Energy. The projects focus on scalability and usability, networked microgrids, and machine learning for a more resilient, flexible and secure power grid.

Two forms of magnesium material were processed into tubing using PNNL’s Shear Assisted Processing and Extrusion™ technology. Both materials were found to have quite similar and improved properties—even though they began vastly different.

A new drug delivery method designed by researchers at PNNL and Washington State University (WSU) has shown it can target and kill lung cancer cells.

With support from DOE’s Office of Electricity and National Grid, PNNL led a groundbreaking study to accurately assess the full value of grid energy storage investments across a wide variety of use cases.

Two Chief Engineers at PNNL given Presidential Early Career Award for Scientists and Engineers

When two powerful earthquakes rocked southern California earlier this month, officials’ attention focused, understandably, on safety. How many people were injured? Were buildings up to code? How good are we at predicting earthquakes?

A PNNL study that evaluated the use of friction stir technology on stainless steel has shown that the steel resists erosion more than three times that of its unprocessed counterpart.

PNNL has developed a unique suite of tools that utilize satellite imagery to generate timely damage assessments with revealing detail.

PNNL has developed a technology to manufacture rods and tubes directly from high-performance aluminum alloy powder—in just one single step.

Scientists have taken one of the most detailed looks ever at levels of soluble amyloid beta in the brain.

PNNL scientist Wei-Jun Qian and colleagues have contributed to a study that offers clues for delaying or even preventing the autoimmune attack that’s at the core of type-1 diabetes.

PNNL researchers today published a pair of papers, in Cell and in Nature, exploring the effects of the gut microbiome on our health, including autism, brain function, and inflammatory bowel disease.

His patents involve novel MS and IMS technologies that, in the end, have enabled a deeper understanding of living systems.

PNNL researchers have devised a way to measure and distinguish tiny amounts of phosphorylated proteins, an approach that could be used in research to help treat diseases such as diabetes and cancer.

The structure of a fundamental electrical switch in the brain has been revealed, thanks to PNNL researchers working together with counterparts at Oregon Health & Science University (OHSU).

PNNL scientists have taken one of the most in-depth looks ever at the riot of protein activity that underlies colon cancer and have identified potential new molecular targets to try to stop the disease.

A new technology that offers a novel way to manufacture extrusions with unprecedented improvements in material properties recently received a U.S. patent.

One of the most common and deadly complications from a heart attack is kidney failure. New research indicates that a specific protein in the bloodstream created after cardiac arrest may be the culprit...

Our gut’s microbial community is not unlike a country club membership. We know who’s a member, but we may not know how each contributes to the overall function or health of the club....

A detailed analysis of blood samples from Ebola patients in Sierra Leone is providing clues about the progression of the effects of the virus and potential treatment pathways. The findings point to a critical role for a molecular pathway.